Literature DB >> 23102207

Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.

Emmanuelle Dubost1, Noé Dumas, Christine Fossey, Rosa Magnelli, Sabrina Butt-Gueulle, Céline Ballandonne, Daniel H Caignard, Fabienne Dulin, Jana Sopkova de-Oliveira Santos, Philippe Millet, Yves Charnay, Sylvain Rault, Thomas Cailly, Frederic Fabis.   

Abstract

The work described herein aims at finding new potential ligands for the brain imaging of 5-HT(4) receptors (5-HT(4)Rs) using single-photon emission computed tomography (SPECT). Starting from the nonsubstituted phenanthridine compound 4a, exhibiting a K(i) value of 51 nM on the 5-HT(4)R, we explored the structure-affinity in this series. We found that substitution in position 4 of the tricycle with a fluorine atom gave the best result. Introduction of an additional nitrogen atom inside the tricyclic framework led to an increase of both the affinity and selectivity for 5-HT(4)R, suggesting the design of the antagonist 4v, exhibiting a high affinity of 0.04 nM. Several iodinated analogues were then synthesized as potential SPECT tracers. The iodinated compound 11d was able to displace the reference radioiodinated 5-HT(4)R antagonist (1-butylpiperidin-4-yl)methyl-8-amino-7-iodo[(123)I]-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate {[(123)I]1, [(123)I]SB 207710} both in vitro and in vivo in brain. Compound 11d was radiolabeled with [(125)I]iodine, providing a potential SPECT candidate for brain imaging of 5-HT(4)R.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23102207      PMCID: PMC3509320          DOI: 10.1021/jm300943r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  52 in total

1.  Protein structure modeling with MODELLER.

Authors:  Narayanan Eswar; David Eramian; Ben Webb; Min-Yi Shen; Andrej Sali
Journal:  Methods Mol Biol       Date:  2008

2.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

3.  A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930.

Authors:  A Dumuis; R Bouhelal; M Sebben; J Bockaert
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

4.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

5.  Improved alignment of weakly homologous protein sequences using structural information.

Authors:  J Gracy; L Chiche; J Sallantin
Journal:  Protein Eng       Date:  1993-11

6.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

7.  SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties.

Authors:  Paul C Moser; Olivier E Bergis; Samir Jegham; Alistair Lochead; Elee Duconseille; Jean-Paul Terranova; Dominique Caille; Isabelle Berque-Bestel; Frank Lezoualc'h; Rodolphe Fischmeister; Aline Dumuis; Joel Bockaert; Pascal George; Philippe Soubrié; Bernard Scatton
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

8.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens.

Authors:  Alexandra Jean; Grégory Conductier; Christine Manrique; Constantin Bouras; Philippe Berta; René Hen; Yves Charnay; Joël Bockaert; Valérie Compan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

10.  Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist.

Authors:  A J Kaumann; L M Gaster; F D King; A M Brown
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

View more
  5 in total

1.  Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer's Disease Treatment through Rigidification Strategy.

Authors:  Cédric Lecoutey; Rémi Legay; Audrey Davis; Jana Sopková-de Oliveira Santos; Patrick Dallemagne; Christophe Rochais
Journal:  Molecules       Date:  2021-04-26       Impact factor: 4.411

2.  Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor.

Authors:  Hongguang Ma; Huiqun Wang; James C Gillespie; Rolando E Mendez; Dana E Selley; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2021-03-22       Impact factor: 2.940

3.  From Isocyanides to Iminonitriles via Silver-mediated Sequential Insertion of C(sp3)-H Bond.

Authors:  Huiwen Chi; Hao Li; Bingxin Liu; Rongxuan Ye; Haoyang Wang; Yin-Long Guo; Qitao Tan; Bin Xu
Journal:  iScience       Date:  2019-11-01

4.  Data-Driven Analysis of Fluorination of Ligands of Aminergic G Protein Coupled Receptors.

Authors:  Wojciech Pietruś; Rafał Kurczab; Dagmar Stumpfe; Andrzej J Bojarski; Jürgen Bajorath
Journal:  Biomolecules       Date:  2021-11-08

5.  Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease.

Authors:  Julien Lalut; Hugo Payan; Audrey Davis; Cédric Lecoutey; Rémi Legay; Jana Sopkova-de Oliveira Santos; Sylvie Claeysen; Patrick Dallemagne; Christophe Rochais
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.